Shandong Luye Pharmaceutical Co., Ltd. clinical trials
A subsidiary of Luye Pharma Group Ltd.
The registry lists 4 studies whose lead sponsor is Shandong Luye Pharmaceutical Co., Ltd.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jan 25, 2011.
Registry sponsor names on this page
- Shandong Luye Pharmaceutical Co., Ltd.4 studies
Something wrong with this grouping? Tell us on the Luye Pharma Group Ltd. page.
Studies
Recruiting first, then most recently updated. Showing 4 of 4. All Luye Pharma Group Ltd. studies →
- Study of Huperzine A Sustained-Release Tablets in Patients With Alzheimer's DiseaseStatus unknownNCT01282619Phase 2/3
Sponsor listed in the registry: Shandong Luye Pharmaceutical Co., Ltd.
- Pharmacokinetics Study of Liposomal Paclitaxel in HumansCompletedNCT00606515Phase 4
Sponsor listed in the registry: Shandong Luye Pharmaceutical Co., Ltd.
- A Clinical Trial of a Radiation Sensitizer in Radiochemotherapy for Thoracic Esophageal Squamous CarcinomaStatus unknownNCT00642239Phase 4
Sponsor listed in the registry: Shandong Luye Pharmaceutical Co., Ltd.
- China Cimicifuga Trial of Climacteric Complaint ControlStatus unknownNCT00622986Phase 4
Sponsor listed in the registry: Shandong Luye Pharmaceutical Co., Ltd.